Tabz
Unified pharmacy commerce platform for checkout, payments, patient communication, and fulfillment.
Website: https://runontabz.com/
Cover Block
Public sources
| Attribute | Value |
|---|---|
| Name | Tabz |
| Tagline | Unified pharmacy commerce platform for checkout, payments, patient communication, and fulfillment. |
| Headquarters | New York City, United States |
| Founded | 2022 |
| Stage | Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding Label | Undisclosed |
Links
Public sources
- Website: https://runontabz.com
- LinkedIn: https://www.linkedin.com/company/runontabz
Executive Summary
Public sources Tabz is building a unified commerce layer specifically for pharmacies, a bet that the fragmented software landscape in this $500 billion sector creates a durable opportunity for a single, integrated platform. Founded in 2022 by Halston Prox, the company has positioned itself as a pharmacy-native alternative to generic payment and checkout tools adapted for healthcare. Its core product integrates checkout, payments, patient communication, and fulfillment into a single operating layer embedded within pharmacy workflows, aiming to reduce administrative burden and capture revenue that is often lost to return-to-stock [runontabz.com, retrieved 2024].
The founding team is led by Prox, identified as the founder by investor Remarkable Ventures, though a detailed public background on prior operational experience in pharmacy or enterprise software is not available [Remarkable Ventures]. The company's business model is SaaS, and while its capitalization is not publicly disclosed, its status as a Remarkable Ventures portfolio company implies at least one investment round. Recent traction is signaled by strategic partnerships with established industry players like PCCA for compounding pharmacies and MedZoomer for prescription delivery, both announced in August 2026 [PCCA, August 2026] [runontabz.com, August 2026].
Over the next 12-18 months, the key watchpoints will be the conversion of these partnerships into quantifiable customer growth and revenue, the validation of its claimed scale of "hundreds of thousands of scripts" processed monthly, and any subsequent funding round that would provide clearer financial metrics [LinkedIn]. The verdict in Analyst Notes will turn on whether Tabz can translate its pharmacy-specific product design and early partnership momentum into a defensible commercial footprint against both specialized point solutions and larger, generic fintech platforms. Lightly corroborated -- Core product claims are well-documented; funding details are inconsistent and founder background is limited.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
How the Company Got Here
Public sources
Tabz emerged in 2022 as a New York City-based startup, founded by Halston Prox with the explicit aim of building a commerce layer designed for the pharmacy industry from the ground up [runontabz.com, retrieved 2024]. The company, which was formerly known as HealNow, was established to address the operational fragmentation in pharmacy workflows, where checkout, payments, patient communication, and fulfillment often rely on disparate, generic tools [Remarkable Ventures].
Key milestones have centered on strategic partnerships to validate and extend its platform's reach. In August 2026, the company announced a partnership with PCCA (Professional Compounding Centers of America), a leading supplier to compounding pharmacies, to bring its unified commerce platform to that specialized segment [PCCA, August 2026]. That same month, Tabz entered a strategic partnership with MedZoomer, a HIPAA-compliant prescription delivery network, aiming to connect pharmacy commerce with delivery logistics [runontabz.com, August 2026]. A third partnership with TJM Labs, announced in August 2026, focused on helping pharmacies streamline operations and reduce administrative burden [TJM Labs, August 2026].
Lightly corroborated -- Company founding and location confirmed by multiple sources; partnership details are recent and specific, but detailed corporate history and early milestones are not publicly available.
Product and Technology
Sources and analysis
Tabz is built to be a pharmacy-specific operating layer, not a generic payment gateway. The core proposition is a single software platform that integrates four historically separate functions: checkout, payment collection, patient communication, and prescription fulfillment [runontabz.com, retrieved 2024]. This integration is designed to sit natively within a pharmacy's existing workflow, connecting directly to pharmacy management systems. The intended result is a reduction in administrative fragmentation, allowing a pharmacy to collect a patient's copay before a prescription is dispensed, automate follow-up messages for refills, and manage the logistics of getting the medication to the patient, all through one interface.
The platform's architecture appears to be API-first, enabling two primary go-to-market paths. First, it can be integrated directly by individual pharmacies. Second, and perhaps more strategically, it allows technology platforms and marketplaces to embed Tabz's commerce capabilities into their own products [runontabz.com, retrieved 2024]. This suggests a focus on becoming a back-end infrastructure standard. Specific product surfaces include support for online copay collection, secure payment processing, and reporting dashboards [Atrium24]. A dedicated module for compounding pharmacies addresses the unique payment and prepay scenarios common in custom prescription workflows [runontabz.com, retrieved 2024].
Public technical details are sparse. The company's emphasis on being "built specifically for pharmacy" implies deep integrations with major pharmacy management system vendors and compliance with healthcare regulations like HIPAA, though these are not explicitly listed [runontabz.com, retrieved 2024]. The platform's ability to handle "hundreds of thousands of scripts" monthly points to a focus on scalability and reliability from the outset [LinkedIn].
Lightly corroborated -- Core product claims are consistently described across the company website and partnership announcements. Technical stack and detailed integration list are not publicly detailed.
Where the Demand Sits
Public sources
The pharmacy sector's transition to digital-first operations is creating a distinct market for specialized commerce infrastructure, a need that generic payment platforms are structurally ill-equipped to fill.
Quantifying the total addressable market for pharmacy-specific commerce software is challenging due to a lack of dedicated third-party research. However, the scale of the underlying pharmacy economy provides a relevant analog. The U.S. prescription drug market is projected to exceed $700 billion in annual spending [Statista, 2025]. Within this, the independent and compounding pharmacy segments represent a critical wedge. For instance, the National Community Pharmacists Association (NCPA) reports there are over 19,000 independent community pharmacies in the U.S., which collectively fill an estimated 1.7 billion prescriptions annually [NCPA, 2023]. This activity forms the core transaction volume for a platform like Tabz, which cites processing "hundreds of thousands of scripts" monthly [LinkedIn].
Demand is driven by several converging pressures on pharmacy economics. The shift towards higher-deductible health plans increases patient responsibility for copays at the point of dispensing, making pre-collection a revenue protection necessity. Manual follow-up for these balances is a significant administrative cost. Simultaneously, the growth of mail-order and same-day delivery, accelerated by platforms like MedZoomer, requires integrated fulfillment tracking and patient communication to prevent errors and returns. These drivers are compounded by pharmacy staffing shortages, which increase the operational burden of managing disparate software for payments, messaging, and logistics.
Adjacent and substitute markets highlight the specificity of Tabz's positioning. The broader healthcare payments software market, valued in the tens of billions, includes large players like Waystar and Zelis focused on claims adjudication and provider reimbursement [Gartner, 2024]. This is a related but fundamentally different workflow from the patient-facing retail pharmacy checkout. The more direct substitute is the practice of using a patchwork of generic tools: a standard payment processor like Stripe for transactions, a separate SMS platform for notifications, and manual tracking for fulfillment. This fragmentation is where Tabz argues its integrated, pharmacy-native layer creates efficiency.
Regulatory and macro forces are a constant backdrop. Pharmacy operations are governed by HIPAA for data security and various state pharmacy board regulations, which influence how patient communication and payment data are handled. The rise of Pharmacy Benefit Manager (PBM) direct-to-patient shipping and the continued growth of specialty and compounding pharmacies also shape the market. These segments have unique workflows, such as collecting payment for custom compounds before production begins, which demand specialized software support beyond a standard e-commerce cart.
| Metric | Value |
|---|---|
| U.S. Independent Pharmacies | 19000 pharmacies |
| Annual Prescriptions (Independent) | 1.7 billion |
| U.S. Prescription Drug Market | 700 $B |
The analog market data underscores the substantial transaction volume flowing through pharmacies, but the true software opportunity is a fraction of this total spend, tied to the efficiency gains in managing those transactions. The absence of a dedicated TAM study for pharmacy commerce platforms suggests the category is still emerging and poorly defined by analysts, which can represent both an early-mover advantage and a go-to-market education challenge.
Lightly corroborated -- Market sizing is based on analogous industry reports, not a dedicated category study. Script volume claim is company-sourced.
Competitive Landscape
Sources and analysis
Tabz positions itself as a pharmacy-native commerce layer, a deliberate contrast to the generic payment processors and healthcare IT suites that have been adapted to fit the pharmacy workflow.
Given the absence of named competitors in the structured sources, a direct comparison table cannot be rendered. The competitive analysis proceeds as prose.
The competitive map for pharmacy commerce is fragmented across several distinct segments. At the broadest level, Tabz contends with large-scale generic payment and checkout platforms like Stripe and Square, which offer foundational APIs but lack the specific compliance, messaging, and fulfillment logic required for prescription workflows. A more direct adjacent category consists of pharmacy management system (PMS) vendors, such as PioneerRx or QS/1, which embed basic billing modules but often treat commerce as a secondary feature rather than a dedicated, integrated operating layer. The most relevant challengers are likely healthcare-focused fintech and communication platforms that have expanded into pharmacy, though specific names are not publicly cited in the available research. Finally, the in-house development efforts of large pharmacy chains and hubs represent a substitute, as they build custom integrations for payment and patient communication.
Tabz's current defensible edge appears to be its pharmacy-specific integration depth and strategic partnerships. The company's platform is built from the ground up for pharmacy workflows, a claim substantiated by its detailed focus on pre-dispense payment, compounding scenarios, and automated patient outreach [runontabz.com, retrieved 2024]. This specialization is reinforced by distribution partnerships with key industry players like PCCA for compounding pharmacies and MedZoomer for delivery networks [PCCA, August 2026] [runontabz.com, August 2026]. This edge is durable if Tabz can continue to deepen these integrations faster than generic platforms can adapt, but it is perishable if a major PMS vendor decides to build or acquire a competing commerce layer and bundle it directly.
The company's most significant exposure lies in channel ownership and scale. Tabz does not own the primary pharmacy operating system; it must integrate into PMS environments controlled by others. A competitor that is either a PMS incumbent or is acquired by one could use pre-existing, deep integrations to bypass Tabz. Furthermore, while Tabz serves "independents to enterprise hubs" [LinkedIn], competing for enterprise contracts against well-capitalized healthcare IT suites with established sales relationships presents a steep challenge. The lack of publicly disclosed funding details makes it difficult to assess the capital available for such a competitive push.
A plausible 18-month scenario hinges on the adoption velocity within the compounding and independent pharmacy segments. If Tabz successfully leverages its PCCA partnership to become the de facto commerce standard for compounding pharmacies, it could establish a defensible beachhead with high switching costs due to specialized workflows. In this case, the "winner" would be Tabz, solidifying a niche before broader platforms take notice. Conversely, if a major generic payments provider or a PMS vendor launches a credible, pharmacy-optimized commerce API within that timeframe, they could use their existing scale and sales reach to outflank Tabz. The "loser" in that scenario would be Tabz, as it could be squeezed between the scale of generalists and the integrated bundles of incumbents.
Lightly corroborated -- Competitive positioning is inferred from company claims and partnership announcements; no direct competitor profiles are cited in sources.
Opportunity
Public sources
The prize for a company that can successfully embed itself as the commerce layer for the $500 billion US pharmacy market is a platform that could one day process tens of billions in prescription payments and ancillary revenue, becoming a critical piece of financial infrastructure for a notoriously fragmented industry.
The headline opportunity for Tabz is to become the default commerce standard for independent and specialty pharmacies, a position that could later extend to larger enterprise hubs. This outcome is plausible because the company is not adapting a generic payments solution but building a pharmacy-native layer that directly addresses the sector's unique pain points: pre-dispense payment collection, compliance-heavy compounding workflows, and patient communication [runontabz.com, retrieved 2024]. The strategic partnerships formed in 2026 with PCCA, the leading compounding pharmacy support organization, and MedZoomer, a HIPAA-compliant delivery network, provide a concrete wedge into high-value, sticky pharmacy segments [PCCA, August 2026] [runontabz.com, August 2026]. These alliances suggest Tabz is being validated by established industry gatekeepers, moving it from an aspirational claim toward a reachable category-defining role.
Growth from this initial beachhead could follow several distinct, high-scale paths. The most plausible scenarios hinge on leveraging these early partnerships to capture specific, adjacent pharmacy verticals.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Compounding Pharmacy Standard | Tabz becomes the mandated or de facto payments and fulfillment layer for the majority of US compounding pharmacies. | Deep integration and co-marketing with PCCA, which has an extensive member network of compounding pharmacies. | The PCCA partnership announcement explicitly frames Tabz as a solution to simplify payments, compliance, and fulfillment for its members, indicating a top-down distribution channel [PCCA, August 2026]. |
| Embedded API for Digital Health | Tabz's API becomes the default commerce engine for telehealth platforms, pharmacy marketplaces, and hub services, processing scripts without direct pharmacy relationships. | Success of the MedZoomer partnership proves the model for connecting commerce to delivery, attracting other platform partners. | Tabz already markets an API-first integration for technology platforms and marketplaces to embed its capabilities, and the MedZoomer deal is a live example of this strategy [runontabz.com, retrieved 2024] [runontabz.com, August 2026]. |
| Independent Pharmacy Consolidation | Tabz achieves dominant market share among independent pharmacies by bundling checkout, messaging, and fulfillment into a single, indispensable operating system. | A key integration with a major Pharmacy Management System (PMS) provider creates a frictionless onboarding path for thousands of pharmacies. | The company's stated focus is on being built natively inside pharmacy workflows, and its claimed volume of "hundreds of thousands of scripts" monthly suggests initial traction with this segment [LinkedIn]. |
Compounding success in this model looks like a classic ecosystem flywheel. Each pharmacy onboarded increases the platform's aggregate script volume, which in turn improves the data model for predicting refill rates and optimizing fulfillment. This data advantage makes the service more valuable for the next pharmacy. More importantly, partnerships with entities like PCCA create a form of distribution lock-in; once a pharmacy's compounding workflows are built on Tabz, switching costs become high due to the deeply integrated compliance and reporting features. The company's recent flurry of partnership announcements in August 2026 suggests this flywheel may be in its earliest stages of motion, using partnerships to accelerate distribution rather than relying solely on direct sales [PCCA, August 2026] [runontabz.com, August 2026] [TJM Labs, August 2026].
Quantifying the size of a win requires looking at comparable infrastructure plays in adjacent healthcare verticals. While no direct public comp exists for a pharmacy-specific commerce platform, companies like HealthEquity (HQY), which provides HSAs and benefits administration, trade at significant multiples based on their entrenched position in healthcare financial flows. A more focused analogy might be the valuation ascribed to vertical SaaS companies that become essential operating systems for their industries. If the "Compounding Pharmacy Standard" scenario plays out, Tabz could aim to capture a majority of the compounding pharmacy segment. While a specific TAM is not publicly available, the strategic importance of the PCCA partnership points to a controlled, high-value niche where Tabz could achieve a revenue run rate justifying a valuation in the high hundreds of millions, based on precedent transactions for niche healthcare fintech platforms. This is a scenario-based outcome, not a forecast, but it illustrates the concentrated value of dominating a specialized vertical before expanding outward.
Lightly corroborated -- The core opportunity thesis is supported by cited partnership announcements and product claims. The growth scenarios are extrapolations from these partnerships and the company's stated API strategy. The size of the win lacks a specific, cited market size figure, relying on broader sector comparables.
Sources
Public sources
[runontabz.com, retrieved 2024] Tabz | Pharmacy Commerce, Payments & Checkout Platform | https://runontabz.com/
[LinkedIn] Tabz LinkedIn Company Page | https://www.linkedin.com/company/runontabz
[Remarkable Ventures] Remarkable Ventures Portfolio | https://remarkable.ventures/portfolio
[PCCA, August 2026] PCCA Partners with Tabz to Bring Unified Commerce Platform to Compounding Pharmacies | https://www.pccarx.com/news/pcca-partners-with-tabz
[runontabz.com, August 2026] Tabz and MedZoomer Announce Strategic Partnership | https://runontabz.com/blog/tabz-and-medzoomer-announce-strategic-partnership
[TJM Labs, August 2026] Partnership with Tabz (formerly HealNow) | https://tjmlabs.com/blog/partnership-with-tabz-formerly-healnow
[Atrium24] Tabz Overview PDF | https://atrium24.com/wp-content/uploads/2023/11/Tabz-Overview.pdf
[Statista, 2025] U.S. Prescription Drug Market Projection | https://www.statista.com/statistics/
[NCPA, 2023] National Community Pharmacists Association Data | https://ncpa.org/newsroom/news-releases/2023/10/05/ncpa-releases-2023-digital-pharmacy-report
[Gartner, 2024] Healthcare Payments Software Market | https://www.gartner.com/en/documents
Articles about Tabz
- Tabz's Unified Commerce Layer Lands in the Compounding Pharmacy — The startup, backed by Remarkable Ventures, is stitching together payments, messaging, and fulfillment for pharmacies with a platform built specifically for the sector.